J
József Bódis
Researcher at University of Pécs
Publications - 168
Citations - 3724
József Bódis is an academic researcher from University of Pécs. The author has contributed to research in topics: Medicine & Pregnancy. The author has an hindex of 24, co-authored 151 publications receiving 3456 citations. Previous affiliations of József Bódis include Hungarian Academy of Sciences.
Papers
More filters
Journal ArticleDOI
Alpha-1 chain of human haptoglobin as viability marker of in vitro fertilized human embryos: information beyond morphology
TL;DR: Using mass spectrometry, the concentration of haptoglobin alpha-1 chain was determined in spent culture media samples of in vitro fertilized embryos and correlation was found with the outcome of the respective transfer.
Journal ArticleDOI
Spontaneous and gonadotropin-releasing hormone induced human chorionic gonadotropin release from superfused JAR choriocarcinoma cells
TL;DR: JAR choriocarcinoma cells have retained several characteristics of normal trophoblasts and have been used as an in vitro trophoblast model and there is a possibility that cell to cell connections might have an influence on the regulation of hormone synthesis and/or secretion.
Journal ArticleDOI
NGS-Based Application for Routine Non-Invasive Pre-Implantation Genetic Assessment in IVF.
Katalin Gombos,Bence Galik,Bence Galik,Krisztina Kalacs,Krisztina Gödöny,Ákos Várnagy,Donát Alpár,József Bódis,Attila Gyenesei,Attila Gyenesei,Gábor L. Kovács +10 more
TL;DR: In this paper, a comprehensive workflow for a clinically applicable strategy for NIPGT-A based on next-generation sequencing (NGS) technology with the corresponding bioinformatic pipeline was provided.
Journal ArticleDOI
Successful treatment of FIGO stage IV gestational choriocarcinoma occurring 2 months after delivery.
Journal ArticleDOI
Tryptophan catabolism to serotonin and kynurenine in women undergoing in-vitro fertilization.
TL;DR: In IVF patients ovarian hyperstimulation results in a reduction of the availability of tryptophan to catabolic pathways to kynurenine and 5-HT, and outcome measures improved significantly when 5- HT predominated over kyn Laurenine.